Chong Kun Dang Holdings Applies for New Hypertension Drug Approval: Investment Analysis
A New Game Changer in the Hypertension Treatment Market? News of Chong Kun Dang’s application for approval of its new hypertension drug ‘Telminuvo’ has caught the attention of investors. Expected to launch in the second half of 2025, what impact will this new drug have on the growth of Chong Kun Dang Holdings? This article … Read more